Advances in opioid antagonist treatment for opioid addiction.
| dc.contributor.author | Ling, Walter | |
| dc.contributor.author | Mooney, Larissa | |
| dc.contributor.author | Wu, Li-Tzy | |
| dc.date.accessioned | 2020-02-03T04:41:07Z | |
| dc.date.available | 2020-02-03T04:41:07Z | |
| dc.date.issued | 2012-06 | |
| dc.date.updated | 2020-02-03T04:41:07Z | |
| dc.identifier | S0193-953X(12)00019-6 | |
| dc.identifier.issn | 0193-953X | |
| dc.identifier.issn | 1558-3147 | |
| dc.identifier.uri | ||
| dc.language | eng | |
| dc.publisher | Elsevier BV | |
| dc.relation.ispartof | The Psychiatric clinics of North America | |
| dc.relation.isversionof | 10.1016/j.psc.2012.03.002 | |
| dc.subject | Humans | |
| dc.subject | Opioid-Related Disorders | |
| dc.subject | Naltrexone | |
| dc.subject | Adrenergic alpha-Agonists | |
| dc.subject | GABA Agonists | |
| dc.subject | Narcotic Antagonists | |
| dc.subject | Antidepressive Agents | |
| dc.subject | Delayed-Action Preparations | |
| dc.subject | Treatment Outcome | |
| dc.subject | Drug Therapy, Combination | |
| dc.subject | Injections, Intramuscular | |
| dc.subject | Behavior Therapy | |
| dc.subject | Randomized Controlled Trials as Topic | |
| dc.subject | Medication Adherence | |
| dc.subject | Secondary Prevention | |
| dc.title | Advances in opioid antagonist treatment for opioid addiction. | |
| dc.type | Journal article | |
| duke.contributor.orcid | Wu, Li-Tzy|0000-0002-5909-2259 | |
| pubs.begin-page | 297 | |
| pubs.end-page | 308 | |
| pubs.issue | 2 | |
| pubs.organisational-group | School of Medicine | |
| pubs.organisational-group | Duke | |
| pubs.organisational-group | Center for Child and Family Policy | |
| pubs.organisational-group | Sanford School of Public Policy | |
| pubs.organisational-group | Duke Clinical Research Institute | |
| pubs.organisational-group | Institutes and Centers | |
| pubs.organisational-group | Duke Institute for Brain Sciences | |
| pubs.organisational-group | University Institutes and Centers | |
| pubs.organisational-group | Institutes and Provost's Academic Units | |
| pubs.organisational-group | Psychiatry & Behavioral Sciences, Social and Community Psychiatry | |
| pubs.organisational-group | Psychiatry & Behavioral Sciences | |
| pubs.organisational-group | Clinical Science Departments | |
| pubs.organisational-group | Medicine, General Internal Medicine | |
| pubs.organisational-group | Medicine | |
| pubs.publication-status | Published | |
| pubs.volume | 35 |
Files
Original bundle
- Name:
- Ling 2012 Advances in opioid antagonist treatment for opioid addiction..pdf
- Size:
- 252.07 KB
- Format:
- Adobe Portable Document Format